Questions | n (%) | 95% CI |
---|---|---|
1. Which of the following health care professionals is/are responsible for ADRs reporting in your hospital? | ||
a. Doctor | 250 (86.5) | 0.82–0.90 |
b. Pharmacist | 289 (100) | 1 |
c. Nurses | 230 (79.6) | 0.74–0.84 |
2. Do you support “direct ADR reporting” by the patient instead of health care professionals? | ||
a. Yes | 270 (93.4) | 0.94–0.98 |
b. No | 19 (6.6) | 0.04–0.10 |
3. Do you think that ADR reporting and monitoring systems would benefit the patient? | ||
a. Yes | 289 (100) | 1 |
b. No | 0 | – |
4. Do you think pharmacists are the ones to assist physicians in ADR reporting? | ||
a. Yes | 289 (100) | 1 |
b. No | 0 | – |
5. Do you worry about legal problems while you think of ADR? | ||
a. Yes | 91 (31.5) | 0.26–0.37 |
b. No | 198 (68.5) | 0.63–0.74 |
6. Do you feel that ADR reporting is a time-consuming activity with no outcome? | ||
a. Yes | 91 (31.5) | 0.26–0.37 |
b. No | 198 (68.5) | 0.63–0.74 |
7. Do you think reporting is a professional obligation to you? | ||
a. Yes | 120 (41.5) | 0.36–0.47 |
b. No | 10 (3.5) | 0.02–0.06 |
c. Don’t know | 80 (27.7) | 0.23–0.33 |
d. Perhaps | 79 (27.3) | 0.22–0.33 |
8. Do you believe reporting should be made mandatory for practicing pharmacists? | ||
a. Yes | 200 (69.2) | 0.63–0.74 |
b. No | 79 (27.3) | 0.22–0.33 |
c. Don’t know | 10 (3.5) | 0.02–0.06 |
9. Are you interested in participating in an ADR reposting system? | ||
a. Yes | 280 (96.9) | 0.94–0.99 |
b. No | 9 (3.1) | 0.01–0.06 |
10. Do you think there should be a National Pharmacovigilance Program? | ||
a. Yes | 289 (100) | 1 |
b. No | 0 | – |
11. If a National Pharmacovigilance Program is instituted, what is your expectation from it? | ||
a. Someone from the center to coordinate with you. | 273 (94.5) | 0.91–0.97 |
b. Financial compensation for time and energy spent. | 16 (5.5) | 0.03–0.09 |
12. ADR reporting is important in order to: (check all that apply) | ||
a. Enable safe drugs to be used. | 289 (100) | 1 |
b. Measure the incidence of ADRs. | 270 (93.4) | 0.90–0.96 |
c. Identify previously unrecognized ADRs. | 270 (93.4) | 0.90–0.96 |
d. Identify factors that might predispose to an ADR. | 270 (93.4) | 0.90–0.96 |
e. Compare ADRs for drugs in similar therapeutic classes. | 221 (76.5) | 0.71–0.81 |
f. Compare ADRs of the same drug from different drug companies. | 221 (76.5) | 0.71–0.81 |
13. In your opinion, pharmacist is encouraged to report ADRs when? (check all that apply) | ||
a. The reaction is of a serious nature | 289 (100) | 1 |
b. The reaction is unusual | 240 (83) | 0.78–0.87 |
c. The reaction is to a new product | 240 (83) | 0.78–0.87 |
d. The reaction is not reported before a particular drug | 240 (83) | 0.78–0.87 |
e. The reaction is well recognized for a particular drug | 159 (55) | 0.49–0.61 |
14. In your opinion, pharmacists may be discouraged to report ADRs when: (check all that apply) | ||
a. Level of clinical knowledge makes it difficult to decide whether or not an ADR has occurred | 18 (6.2) | 0.03–0.10 |
b. Uncertain Association Between the drug and the adverse reaction | 7 (2.4) | 0.01–0.05 |
c. The ADR is too trivial to report | 3 (1) | 0.01–0.03 |
d. Concern that a report will generate extra work | 3 (1) | 0.01–0.03 |
e. ADR reporting form is not available when needed | 2 (0.7) | 0.01–0.02 |
f. Not Enough Information Available from the patient | 280 (96.9) | 0.94–0.99 |
g. Lack of time to fill in a report | 230 (79.6) | 0.74–0.84 |
h. Did not know how to report | 17 (5.9) | 0.03–0.09 |
i. Unaware of the need to report an ADR | 280 (96.9) | 0.94–0.99 |
j. Consider if the doctors’ responsibility | 2 (0.7) | 0.01–0.02 |
k. Fear of legal liability | 0 | – |
15. The perception of a safety culture revolves around which of the following statements: | ||
a. Why waste our time on safety | 0 | – |
b. We Do Something When We Have an incident | 135 (46.7) | 0.41–0.43 |
c. We have systems in place to manage all identified risks | 6 (2.1) | 0.01–0.04 |
d. We are always on the alert for risks that might emerge | 7 (2.4) | 0.01–0.05 |
e. Risk management is an integral part of everything that we do | 141 (48.8) | 0.43–0.55 |